Cholangitis secondary prevention

Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]

Cholangitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cholangitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cholangitis secondary prevention On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cholangitis secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cholangitis secondary prevention

CDC on Cholangitis secondary prevention

Cholangitis secondary prevention in the news

Blogs on Cholangitis secondary prevention

Directions to Hospitals Treating Cholangitis

Risk calculators and risk factors for Cholangitis secondary prevention

Overview

Secondary prevention strategies for cholangitis includes continued treatment of predisposing causes in appropriate patients to prevent the recurrence of cholangitis.

Secondary Prevention

Secondary prevention strategies for cholangitis include continued treatment of predisposing causes in appropriate patients to avoid the recurrence of cholangitis :

  • Infection due to instrumentation of biliary tract:[1][2][3]
    • Appropriate antibiotics
    • Biliary drainage
  • Cholangitis due to gallstones/cholelithiasis:[4][5][6]
    • Initially endoscopic papilotomy/sphincterotomy should be done for biliary drainage and stone removal.
    • Laparoscopic cholecystectomy should be followed thereafter as doing cholecystectomy alone would not prevent recurrence of cholangitis.

References

  1. Bu LN, Chen HL, Chang CJ, Ni YH, Hsu HY, Lai HS; et al. (2003). "Prophylactic oral antibiotics in prevention of recurrent cholangitis after the Kasai portoenterostomy". J Pediatr Surg. 38 (4): 590–3. doi:10.1053/jpsu.2003.50128. PMID 12677572.
  2. Cybulski Z, Solarski J, Majewski W (1994). "[Infection as a risk factor in biliary system surgery]". Wiad Lek. 47 (15–16): 619–24. PMID 7716962.
  3. van den Hazel SJ, Speelman P, Tytgat GN, Dankert J, van Leeuwen DJ (1994). "Role of antibiotics in the treatment and prevention of acute and recurrent cholangitis". Clin Infect Dis. 19 (2): 279–86. PMID 7986900.
  4. Holzheimer, R (2001). Surgical treatment : evidence-based and problem-oriented. München New York: Zuckschwerdt. ISBN 978-3886037148.
  5. Poon RT, Liu CL, Lo CM, Lam CM, Yuen WK, Yeung C; et al. (2001). "Management of gallstone cholangitis in the era of laparoscopic cholecystectomy". Arch Surg. 136 (1): 11–6. PMID 11146767.
  6. Himal HS (1991). "The role of endoscopic papillotomy in ascending cholangitis". Am Surg. 57 (4): 241–4. PMID 2053744.


Template:WikiDoc Sources